PRESS  RELEASE
        
 
        
Grupo Casa  Saba, S.A.B. de C.V. (“GCS”) (BMV: SAB*) informs that, as of today, it has signed  a stock purchase agreement with Pharma Equity Global Fund LLC and World Global  Equity Fund LLC to sell all of its subsidiaries dedicated to the pharmaceutical  products wholesale and distribution business for a total consideration of  approximately $4,500 million Mexican Pesos. The transaction includes the  assumption of all liabilities related to this business as well as the entirety  of its operational and real estate assets.
        
The closing  of the transaction is subject to customary corporate and regulatory approvals for  this type of transaction.
        
As part of  its strategy to strengthen its balance sheet, GCS will use the net proceeds  from such transaction to reduce bank debt at the GCS level. As a result of this  transaction, GCS will focus exclusively on its pharmacy retail business in  Mexico and Chile and its GNC franchise in Brazil. 
        
Estructura  Partners acted as exclusive financial advisor to GCS.